Diagnostic accuracy of diffusion-weighted imaging in differentiating glioma recurrence from posttreatment-related changes: a meta-analysis

References

• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. Erratum in: CA Cancer J Clin. 2021 Jul;71(4):359.
   PubMed Web of Science ®Google Scholar
• Miller KD, Fidler–Benaoudia M, Keegan TH, et al., Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 70(6): 443–459. 2020.
   PubMed Web of Science ®Google Scholar
• Davis ME. Epidemiology and overview of gliomas. Semin Oncol Nurs. 2018;34(5):420–429.
   PubMed Web of Science ®Google Scholar
• Jiang T, Nam DH, Ram Z, et al. Clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2021;499:60–72.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu H, Tong H, et al. Clinical applications of contrast-enhanced perfusion MRI techniques in gliomas: recent advances and current challenges. Contrast Media Mol Imaging. 2017;2017:7064120.
   PubMedGoogle Scholar
• Nagane M, Kobayashi K, Tanaka M, et al. Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report. Int J Clin Oncol. 2014;19(1):16–23.
   PubMed Web of Science ®Google Scholar
• Cha J, Kim ST, Kim HJ, et al. Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis. AJNR Am J Neuroradiol. 2014;35(7):1309–1317.
   PubMed Web of Science ®Google Scholar
• Reimer C, Deike K, Graf M, et al., Differentiation of pseudoprogression and real progression in glioblastoma using ADC parametric response maps. PLoS One. 12(4): e0174620. 2017.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ma L, Shu C, et al. Diagnostic accuracy of diffusion MRI with quantitative ADC measurements in differentiating glioma recurrence from radiation necrosis. J Neurol Sci. 2015;351(1–2):65–71.
   PubMed Web of Science ®Google Scholar
• Tsakiris C, Siempis T, Alexiou GA, et al. Differentiation between true tumor progression of glioblastoma and pseudoprogression using diffusion-weighted imaging and perfusion-weighted imaging: systematic review and meta-analysis. World Neurosurg. 2020;144:e100–e109.
   PubMed Web of Science ®Google Scholar
• Schwender H, Ruczinski I. Logic regression and its extensions. In: Dunlap JC, Moore JH, editors. Advances in genetics. Vol. 72. London: Academic Press; 2010. p. 25–45.
   Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536.
   PubMed Web of Science ®Google Scholar
• Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, et al. Assessing heterogeneity in meta-analysis: q statistic or I2 index? Psychol Methods. 2006;11(2):193–206.
   PubMed Web of Science ®Google Scholar
• Hamza TH, van Houwelingen HC, Heijenbrok-Kal MH, et al. Associating explanatory variables with summary receiver operating characteristic curves in diagnostic meta-analysis. J Clin Epidemiol. 2009;62(12):1284–1291.
   PubMed Web of Science ®Google Scholar
• Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785–794.
   PubMed Web of Science ®Google Scholar
• Leeflang MMG. Systematic reviews and meta-analyses of diagnostic test accuracy. Clin Microbiol Infect. 2014;20(2):105–113.
   PubMed Web of Science ®Google Scholar
• Reid JL, Fagan ME, Zahawi RA. Positive site selection bias in meta-analyses comparing natural regeneration to active forest restoration. Sci Adv. 2018;4(5):eaas9143.
   PubMed Web of Science ®Google Scholar
• Zeng QS, Li CF, Liu H, et al. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Int J Radiat Oncol Biol Phys. 2007;68(1):151–158.
   PubMed Web of Science ®Google Scholar
• Matsusue E, Fink JR, Rockhill JK, et al. Distinction between glioma progression and post-radiation change by combined physiologic MR imaging. Neuroradiology. 2010;52(4):297–306.
   PubMed Web of Science ®Google Scholar
• Bobek-Billewicz B, Stasik-Pres G, Majchrzak H, et al. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy. Folia Neuropathol. 2010;48(2):81–92.
   PubMed Web of Science ®Google Scholar
• Meng MZ, Zhou SL, Miao ZC, et al. MR DWI combined with 1H-MRS analysis of multi-parameter in distinction of brain glioma recurrence and post-radiation brain injuries. Chin J Med Imaging Technol. 2011;27(5): 905–909
   Google Scholar
• Fink JR, Carr RB, Matsusue E, et al. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects. J Magn Reson Imaging. 2012;35(1):56–63.
   PubMed Web of Science ®Google Scholar
• Sha L, Fan GG, Cao Q, et al. MR perfusion weighted imaging combined with MR diffusion weighed imaging in differentiating recurrent cerebral gliomas and radiation injury. J Chin Clin Med Imaging. 2013;24. 841–845.
   Google Scholar
• Di Costanzo A, Scarabino T, Trojsi F, et al. Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach. La Radiol Med. 2014;119(8):616–624.
   PubMed Web of Science ®Google Scholar
• Kim HS, Suh CH, Kim N, et al. Histogram analysis of intravoxel incoherent motion for differentiating recurrent tumor from treatment effect in patients with glioblastoma: initial clinical experience. AJNR Am J Neuroradiol. 2014;35(3):490–497.
   PubMed Web of Science ®Google Scholar
• Li P, Liu Y, Zhai Z. The preliminary study of glioma recurrence and radiation-induced brain injury on high b-value DWI. J Pract Radiol. 1626;1630.
   Google Scholar
• Prager AJ, Martinez N, Beal K, et al. Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. AJNR Am J Neuroradiol. 2015;36(5):877–885.
   PubMed Web of Science ®Google Scholar
• Liu T, Zheng Y. Application value of proton magnetic resonance spectroscopy combined with diffusion weighted imaging in differentiating postoperative recurrence and radiation injury of brain glioma. Guangxi Med J. 2016;38(5):711–714.
   Google Scholar
• Kazda T, Bulik M, Pospisil P, et al. Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging. Neuroimage Clin. 2016;11:316–321.
   PubMed Web of Science ®Google Scholar
• Khan UA, Rennert RC, White NS, et al. Diagnostic utility of restriction spectrum imaging (RSI) in glioblastoma patients after concurrent radiation-temozolomide treatment: a pilot study. J Clin Neurosci. 2018;58:136–141.
   PubMed Web of Science ®Google Scholar
• Pyka T, Hiob D, Preibisch C, et al. Diagnosis of glioma recurrence using multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI. Eur J Radiol. 2018;103:32–37.
   PubMed Web of Science ®Google Scholar
• Zakhari N, Taccone MS, Torres C, et al. Diagnostic accuracy of centrally restricted diffusion in the differentiation of treatment-related necrosis from tumor recurrence in high-grade gliomas. AJNR Am J Neuroradiol. 2018;39(2):260–264.
   PubMed Web of Science ®Google Scholar
• Ren LF, Zhang H, Wang XC, et al. Preliminary study of magnetic resonance dynamic contrast enhancement combined with diffusion weighted imaging to identify high grade glioma recurrence and treatment-related changes. Chin J Magn Reson Imaging. 2019;10(9): 655–660.
   Google Scholar
• Yang Y, Yang Y, Wu X, et al. Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas. J Neuro Oncol. 2020;146(2):363–371.
   PubMed Web of Science ®Google Scholar
• Zikou A, Sioka C, Alexiou GA, et al. Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas. Contrast Media Mol Imaging. 2018;2018:6828396.
   PubMedGoogle Scholar
• Thust SC, van den Bent MJ, Smits M. Pseudoprogression of brain tumors. J Magn Reson Imaging. 2018;48(3):571–589.
   Web of Science ®Google Scholar
• Mahase S, Rattenni RN, Wesseling P, et al. Hypoxia-mediated mechanisms associated with antiangiogenic treatment resistance in glioblastomas. Am J Pathol. 2017;187(5):940–953.
   PubMed Web of Science ®Google Scholar
• Yeo DM, Oh SN, Jung CK, et al. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: preliminary results. J Magn Reson Imaging. 2015;41(2):474–480.
   PubMed Web of Science ®Google Scholar
• Ma B, Blakeley JO, Hong X, et al. Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas. J Magn Reson Imaging. 2016;44(2):456–462.
   PubMed Web of Science ®Google Scholar
• Ellingson BM, Malkin MG, Rand SD, et al. Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging. 2010;31(3):538–548.
   PubMed Web of Science ®Google Scholar
• Qin L, Li X, Stroiney A, et al. Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma. Neuroradiology. 2017;59(2):135–145.
   PubMed Web of Science ®Google Scholar
• Aquino D, Gioppo A, Finocchiaro G, et al. MRI in glioma immunotherapy: evidence, pitfalls, and perspectives. J Immunol Res. 2017;2017:5813951.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Choi SH, Park CK, et al. Diffusion-weighted MR imaging for the differentiation of true progression from pseudoprogression following concomitant radiotherapy with temozolomide in patients with newly diagnosed high-grade gliomas. Acad Radiol. 2012;19(11):1353–1361.
   PubMed Web of Science ®Google Scholar
• Jena A, Taneja S, Jha A, et al. Multiparametric evaluation in differentiating glioma recurrence from treatment-induced necrosis using simultaneous (18)F-FDG-PET/MRI: a single-institution retrospective study. AJNR Am J Neuroradiol. 2017;38(5):899–907.
   PubMed Web of Science ®Google Scholar
• Elshafeey N, Kotrotsou A, Hassan A, et al. Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma. Nat Commun. 2019;10(1):317.
   PubMedGoogle Scholar